Bharat Biotech gets DCGI's nod to conduct intranasal booster dose trials
Saturday, May 21, 2022
  • Circulation
  • Advertise
  • About Us
  • Contact Us
  • Privacy Policy
Organiser
  • ‌
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Sports
  • Business
  • More
    • RSS in News
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
SUBSCRIBE
No Result
View All Result
Organiser
  • ‌
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Sports
  • Business
  • More
    • RSS in News
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
No Result
View All Result
Organiser
No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Opinion
  • Analysis
  • Culture
  • Defence
  • RSS in News
  • Subscribe
Home Bharat

Bharat Biotech gets DCGI’s nod to conduct intranasal booster dose trials

WEB DESK by WEB DESK
Jan 28, 2022, 04:29 pm IST
in Bharat, Delhi, Health
Jeay Sindh Freedom Movement chairman Sohail Abro

Jeay Sindh Freedom Movement chairman Sohail Abro

Share on FacebookShare on TwitterTelegramEmail

New Delhi: The Drugs Controller General of India (DCGI) on Friday granted permission to Bharat Biotech to conduct clinical trials of intranasal vaccine BBV154.

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) had also recommended the internasal vaccine clinical trials during the last meeting.

The NOC letter issued by the DCGI read, "Central Licensing Authority hereby permits Bharat Biotech International limited to conduct clinical trials of the new drug or investigational new drug."

The dosage form of the vaccine is liquid for the intranasal route of administration and every single dose contains 0.5ml.

The trials of the Intranasal vaccine will take place at nine different sites of the country.

The trials will be conducted at Atman Hospital, Ahmedabad, Gujarat; AIIMS, Delhi and Patna; Oyster and Pearls Hospitals, Pune; Pt.BD Sharma Postgraduate Institute of Medical Sciences at Rohtak, Haryana; Acharya Vinobha Bhave Rural Hospital, Wardha; Jeevan Rekha Hospital, Belagavi; Rana hospital, Gorakhpur; and Prakhar Hospital, Uttar Pradesh.

"The Phase -3 clinical trial should be conducted as per protocol multi-center study to compare immunogenicity and safety of BBV154 with COVAXIN." read the letter. (ANI)

ShareTweetSendShareSend
Previous News

Assam: Police arrested Burhanuddin, Gulzar and Safiqul while trying to smuggle cows; Police recovered 58 cows on their way to the slaughterhouse

Next News

Gujarat Model: A Template For Growth

Related News

Bajrang Dal holds massive ‘Shourya Rally’ in Kerala, sends stern warning to Islamist terrorists

Bajrang Dal holds massive ‘Shourya Rally’ in Kerala, sends stern warning to Islamist terrorists

Union Minister Sarbananda Sonowal to inaugurate the BUMS course of the first-ever Government Unani Medical College & Hospital in Jammu & Kashmir

Yoga has given a tremendous fillip to the stature of India at the global stage: Union Minister Sarbananda Sonowal

Mizoram Govt seeks EAM S Jaishankar’s help for supply of gas and oil through Bangladesh

Mizoram Govt seeks EAM S Jaishankar’s help for supply of gas and oil through Bangladesh

Patriotic People’s Front Assam demands a fair NRC with 1951 cut-off  year

Patriotic People’s Front Assam demands a fair NRC with 1951 cut-off year

‘More monkeypox cases likely’: WHO confirms 80 cases in 11 countries

‘More monkeypox cases likely’: WHO confirms 80 cases in 11 countries

Yogi, Uddhav Thackeray, Jagan Reddy in Inter State Council panel headed by Amit Shah

Yogi, Uddhav Thackeray, Jagan Reddy in Inter State Council panel headed by Amit Shah

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Bajrang Dal holds massive ‘Shourya Rally’ in Kerala, sends stern warning to Islamist terrorists

Bajrang Dal holds massive ‘Shourya Rally’ in Kerala, sends stern warning to Islamist terrorists

Union Minister Sarbananda Sonowal to inaugurate the BUMS course of the first-ever Government Unani Medical College & Hospital in Jammu & Kashmir

Yoga has given a tremendous fillip to the stature of India at the global stage: Union Minister Sarbananda Sonowal

Mizoram Govt seeks EAM S Jaishankar’s help for supply of gas and oil through Bangladesh

Mizoram Govt seeks EAM S Jaishankar’s help for supply of gas and oil through Bangladesh

Patriotic People’s Front Assam demands a fair NRC with 1951 cut-off  year

Patriotic People’s Front Assam demands a fair NRC with 1951 cut-off year

‘More monkeypox cases likely’: WHO confirms 80 cases in 11 countries

‘More monkeypox cases likely’: WHO confirms 80 cases in 11 countries

Yogi, Uddhav Thackeray, Jagan Reddy in Inter State Council panel headed by Amit Shah

Yogi, Uddhav Thackeray, Jagan Reddy in Inter State Council panel headed by Amit Shah

Turkey may drop opposing NATO entry to  Finland and Sweden

Turkey may drop opposing NATO entry to Finland and Sweden

Indic Wisdom: Awakening Through Yog

Indic Wisdom: Awakening Through Yog

Book Review: English not Must for Success

Book Review: English not Must for Success

Shivling found in Gyanvapi Premises is one of 12 Jyotirlingas, says VHP

Shivling found in Gyanvapi Premises is one of 12 Jyotirlingas, says VHP

  • Circulation
  • Advertise
  • About Us
  • Contact Us
  • Privacy Policy

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • Special Report
  • Sci & Tech
  • Entertainment
  • Education
  • Books
  • Interviews
  • Travel
  • Health
  • Obituary
  • Subscribe
  • About Us
  • Advertise
  • Circulation
  • Contact Us
  • Privacy Policy

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies